Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 703624Generated: October 31, 2026

Methyl iodide → 1-[4-(t-Butyldimethylsilyl)oxy-2,6,6-trimethylcyclohex-1-enyl]pent-1-en-3-one

https://huagongshe.com/reaction/703624

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethyl iodideHCID 6328—
ReactantDiisopropylamineHCID 7912—
ReactantAmmonium ChlorideHCID 25517—
ReactantLithium diisopropylamideHCID 2724682—
Reactant4-[4-(t-Butyldimethylsilyl)oxy-2,6,6-trimethylcyclohex-1-enyl]but-3-en-2-oneHCID 54171858—
ReactantButyllithiumHCID 178418339—
SolventTetrahydrofuranHCID 8028—
SolventHexaneHCID 8058—
SolventHexamethylphosphoramideHCID 12679—
Product1-[4-(t-Butyldimethylsilyl)oxy-2,6,6-trimethylcyclohex-1-enyl]pent-1-en-3-oneHCID 5456269863%

Reaction Conditions

Temperature-78 °C

Reaction Steps

To 3 ml of an anhydrous THF solution containing 375 mg of diisopropylamine was added 2.3 ml of a 1.6M n-hexane solution of n-butyl lithium at 0° C. in a nitrogen atmosphere to prepare LDA in the usual manner. The reaction mixture was cooled to -78° C., and 111 mg of hexamethylphosphoric triamide was added thereto. To the cooled mixture was dropwise added 10 ml of an anhydrous THF solution containing 1.0 g of 4-[4-(t-butyldimethylsilyl)oxy-2,6,6-trimethylcyclohex-1-enyl]-but-3-en-2-one. After the dropwise addition, the mixture was stirred under the same condition for 30 minutes. Then, 5 ml of an anhydrous THF solution of 659 mg of methyl iodide was added dropwise thereto. The reaction mixture was warmed to 0° C., followed by stirring overnight. After completion of the reaction, the reaction mixture was poured into a saturated ammonium chloride aqueous solution and extracted with diethyl ether. The organic layer was washed successively with a saturated sodium chloride aqueous solution and water, and dried over anhydrous magnesium sulfate. The solvent, etc. were removed by distillation under reduced pressure. Purification of the residue by silica gel column chromatography yielded 657 mg (63%) of 1-[4-(t-butyldimethylsilyl)oxy-2,6,6-trimethylcyclohex-1-enyl]pent-1-en-3-one.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04983723
Source datasetuspto-grants-1991_01
ORD IDord-8eb0fc5114e045fdb146de52b9ec7f48
Source noteuspto-grants-1991_01